Eric K Rowinsky

Eric K Rowinsky has an estimated net worth of $17.3 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., BIND Therapeutics, Inc, Verastem, Inc., NEOPROBE CORP, Fortress Biotech, Inc., ADVENTRX PHARMACEUTICALS INC, STEMLINE THERAPEUTICS INC, TAPESTRY PHARMACEUTICALS, INC, and IMCLONE SYSTEMS INC/DE.

2015 was Eric K Rowinsky's most active year for acquiring shares with 10 total transactions. Eric K Rowinsky's most active month to acquire stocks was the month of May. 2015 was Eric K Rowinsky's most active year for disposing of shares, totalling 10 transactions. Eric K Rowinsky's most active month to dispose stocks was the month of February. 2015 saw Eric K Rowinsky paying a total of $1,395,780.06 for 232,608 shares, this is the most they've acquired in one year. In 2015 Eric K Rowinsky cashed out on 59,130 shares for a total of $10,685,355.03, their largest year based on trade value.